Literature DB >> 32963042

Adrenal medullary hyperplasia mimicking pheochromocytoma.

Annalisa Montebello1,2, Michelle Ann Ceci3, Sandro Vella4,2.   

Abstract

A 59-year-old woman, a known case of hypertension, was incidentally diagnosed with a large right-sided adrenal mass. Investigations for a functional adrenal lesion resulted in very high preoperative norepinephrine levels. A right adrenalectomy was performed. Histology showed adrenal medullary hyperplasia (AMH). AMH is a rare diagnosis and its incidence is poorly documented in the literature. This is a benign entity which resembles pheochromocytoma (PCC) in both clinical and biochemical manner. AMH is usually bilateral and may occur in isolation or in association with PCC. In fact, some authors consider it to be a precursor to PCC. Thus, these patients need long-term follow-up in view of the risk of development of PCC later. © BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  adrenal disorders; general surgery; radiology

Mesh:

Substances:

Year:  2020        PMID: 32963042      PMCID: PMC7509954          DOI: 10.1136/bcr-2020-236209

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  11 in total

1.  Adrenal medullary disease in multiple endocrine neoplasia, type 2: pheochromocytoma and its precursors.

Authors:  J A Carney; G W Sizemore; S G Sheps
Journal:  Am J Clin Pathol       Date:  1976-08       Impact factor: 2.493

2.  Isolated left adrenal medullary hyperplasia.

Authors:  Hiroaki Kawano; Takao Ando; Yohei Shida; Daisuke Niino; Koji Maemura; Kioko Kawai
Journal:  J Cardiol Cases       Date:  2019-09-08

3.  A case of unilateral adrenal medullary hyperplasia.

Authors:  Y Maki; S Irie; T Ohashi; H Ohmori
Journal:  Acta Med Okayama       Date:  1989-10       Impact factor: 0.892

4.  Pathological and Genetic Characterization of Bilateral Adrenomedullary Hyperplasia in a Patient with Germline MAX Mutation.

Authors:  Pauline Romanet; Carole Guerin; Pascal Pedini; Wassim Essamet; Frédéric Castinetti; Fréderic Sebag; Philippe Roche; Alberto Cascon; Arthur S Tischler; Karel Pacak; Anne Barlier; David Taïeb
Journal:  Endocr Pathol       Date:  2017-12       Impact factor: 3.943

5.  Pheochromocytoma due to unilateral adrenal medullary hyperplasia.

Authors:  G Qupty; A Ishay; H Peretz; M Dharan; N Kaufman; R Luboshitzky
Journal:  Clin Endocrinol (Oxf)       Date:  1997-11       Impact factor: 3.478

6.  Adrenal medullary hyperplasia: a clinicopathologic study of four cases.

Authors:  F R Rudy; R D Bates; A J Cimorelli; G S Hill; K Engelman
Journal:  Hum Pathol       Date:  1980-11       Impact factor: 3.466

7.  Unilateral adrenal catecholamine excess. Pheochromocytoma or possible sporadic medullary hyperplasia.

Authors:  A Bauman
Journal:  Arch Intern Med       Date:  1982-02

8.  [Diagnosis of adrenal medullary diseases in patients with sporadic or hereditary medullary thyroid carcinoma. A report of 37 cases with 8-year follow-up study].

Authors:  A Miyauchi; F Matsuzaka; K Kuma; K Endo; T Ogihara; M Maeda
Journal:  Nihon Geka Gakkai Zasshi       Date:  1987-10

9.  Association of adrenal medullar and cortical nodular hyperplasia: a report of two cases with clinical and morpho-functional considerations.

Authors:  Gloria Valdés; Eric Roessler; Iván Salazar; Helmar Rosenberg; Carlos Fardella; Pedro Martínez; Alfredo Velasco; Soledad Velasco; Pilar Orellana
Journal:  Endocrine       Date:  2006-12       Impact factor: 3.925

10.  Presentation, Treatment, Histology, and Outcomes in Adrenal Medullary Hyperplasia Compared With Pheochromocytoma.

Authors:  Henrik Falhammar; Adam Stenman; Jan Calissendorff; Carl Christofer Juhlin
Journal:  J Endocr Soc       Date:  2019-06-11
View more
  1 in total

1.  Case Report: Three Rare Cases of Ectopic ACTH Syndrome Caused by Adrenal Medullary Hyperplasia.

Authors:  Yu Cheng; Jie Li; Jingtao Dou; Jianming Ba; Jin Du; Saichun Zhang; Yiming Mu; Zhaohui Lv; Weijun Gu
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-01       Impact factor: 5.555

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.